Anbio Biotechnology Class A Ordinary Shares

NNNN· NASDAQ· Health Care· Health Care Equipment & Services

$10.65+7.58%

2026-08-03

Financials

Valuation Metrics

Anbio Biotechnology Class A Ordinary Shares's Market Cap is $467M. At end of 2025 it was $1.32B. Ranked #2838 of 3,111 in US market (top 91%), #1246 of 1,445 on NASDAQ (top 86%), #174 of 206 in Health Care Equipment & Services (top 84%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$467M	US#2,838/3,111 Sec#174/206
Revenue	$14M	US#2,923/3,111 Sec#205/206
Net Income	$7M	US#2,173/3,111 Sec#109/206
Total Assets	$30M	US#3,067/3,111 Sec#208/206
Net Assets	$30M	US#2,969/3,111 Sec#198/206
Value
P/E	65.24x	US#1,954/3,111 Sec#97/206
P/B	15.50x	US#2,743/3,111 Sec#183/206
P/S	32.68x	US#2,860/3,111 Sec#205/206
EV/EBITDA	89.21x	US#2,422/3,111 Sec#130/206
Profitability
ROE	23.76%	US#432/3,111 Sec#19/206
ROA	23.69%	US#55/3,111 Sec#4/206
Op. Margin	41.54%	US#215/3,111 Sec#3/206
Revenue Growth	-25.07%	US#2,818/3,111 Sec#203/206
Earnings Growth	-21.83%	US#1,673/3,111 Sec#82/206
Financial Health
Debt Ratio	0.29%	US#8/3,111 Sec#1/206
Total Debt	$0.00	US—/3,111 Sec—/206
Cash	$8M	US#2,984/3,111 Sec#206/206
Current Ratio	344.31x	US#15/3,111 Sec#1/206
Net Debt/EBITDA	-1.51x	US#231/3,111 Sec#15/206
Performance
1Y Return	-75.12%	US#3,100/3,111 Sec#203/206
1M Return	-16.14%	US#2,795/3,111 Sec#186/206
From 52W High	-80.62%	US#3,085/3,111 Sec#206/206
1Y MDD	-82.50%	US#3,063/3,111 Sec#203/206
Trading
Volume	121,258 shares	US#3,081/3,111 Sec#205/206
Trading Value	$1M	US#3,092/3,111 Sec#204/206
Per Share
EPS	$0.17	US#1,994/3,111 Sec#106/206
BPS	$0.74	US#2,664/3,111 Sec#186/206